US Patent No: 7,872,109
Number of patents in Portfolio can not be more than 2000
Motilide polymorphs
Stats
-
Jan 18, 2011
Issued date -
Dec 4, 2007
filing date -
11/987,810
serial no -
In Force
status
Importance
Loading Importance Indicators...
Abstract
The invention provides polymorphs of a motilide having a structure represented by formula Ia
Loading the Abstract Image...
First Claim
Related Publications
Loading Related Publications...
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art
| Patent Info | (Count) | # Cites | Year |
|---|---|---|---|
|
|
|||
| 5,538,961 Macrocyclic lactam prokinetic agents | 11 | 1993 | |
| 5,578,579 4"-deoxyerythromycin derivatives | 12 | 1994 | |
| 5,523,401 Macrocyclic lactam prokinetic agents | 11 | 1995 | |
| 5,523,418 Macrocyclic lactam prokinetic agents | 9 | 1995 | |
| 5,554,605 Macrocyclic lactam prokinetic agents | 11 | 1995 | |
| 5,654,411 Process for preparing 4-deoxyerythromycin derivatives | 5 | 1995 | |
| 5,834,438 4"-deoxyerythromycin derivatives | 6 | 1995 | |
| 5,922,849 Process for preparation of N-demethyl-4"-deoxy-erthromycins A and B | 8 | 1996 | |
|
|
|||
| 2002/0094,962 Motilide compounds | 21 | 2001 | |
| 2005/0113,319 11-Deoxy-6,9-ether erythromycin compounds | 3 | 2004 | |
| 2006/0270,616 Motilide compounds | 2 | 2006 | |
| 2007/0135,362 Method for demethylating the 3'-dimethylamino group of erythromycin compounds | 2 | 2006 | |
|
|
|||
| 5,444,051 Erythromycin compounds | 62 | 1993 | |
| 5,561,118 Erythromycin compounds | 25 | 1994 | |
| 5,770,579 Erythromycin compounds | 32 | 1995 | |
|
|
|||
| 5,712,253 Macrocyclic 13-membered ring derivatives of erythromycins A and B | 14 | 1996 | |
| 6,084,079 Process for preparing N-demethyl-N-alkyl erythromycin derivatives | 8 | 1998 | |
|
|
|||
| 5,658,888 Erythromycin derivatives | 19 | 1994 | |
| 5,959,088 Process for producing erythromycin derivatives | 10 | 1998 | |
|
|
|||
| 5,008,249 Therapeutic method of stimulating digestive tract contractile motion in mammals | 10 | 1986 | |
| 5,175,150 Erythromycin derivative | 14 | 1990 | |
|
|
|||
| 5,470,961 14 and/or 15-hydroxy 6,9 hemiacetal erythromycin derivatives | 9 | 1993 | |
|
|
|||
| 4,588,712 (8S)-8-fluoroerythromycin derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them | 6 | 1985 | |
|
|
|||
| 6,169,168 Erythromycin A derivatives | 7 | 1999 | |
Patent Citation Ranking
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 3.5 Year Payment | $1600.00 | $800.00 | $400.00 | Jul 18, 2014 |
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Jul 18, 2018 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Jul 18, 2022 |
| Fee | Large entity fee | small entity fee | micro entity fee |
|---|---|---|---|
| Surcharge - 3.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
| Surcharge - 7.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
| Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
| Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
| Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |